ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05100	Bacterial invasion of epithelial cells	11/99	99/7206	8.69328608383e-08
ko05152	Tuberculosis	13/99	187/7206	1.40016066776e-06
ko05131	Shigellosis	9/99	82/7206	1.54536640446e-06
ko05132	Salmonella infection	9/99	98/7206	6.92380250068e-06
ko04810	Regulation of actin cytoskeleton	14/99	264/7206	1.2948460204e-05
ko04217	Necroptosis	11/99	178/7206	2.92725181068e-05
ko04621	NOD-like receptor signaling pathway	10/99	157/7206	5.33546438968e-05
ko05130	Pathogenic Escherichia coli infection	7/99	77/7206	8.1781891672e-05
ko00512	Mucin type O-glycan biosynthesis	4/99	29/7206	0.000611587873324
ko00520	Amino sugar and nucleotide sugar metabolism	5/99	55/7206	0.000893100893626
ko05133	Pertussis	6/99	87/7206	0.00118892887531
ko04666	Fc gamma R-mediated phagocytosis	7/99	122/7206	0.00137838962221
ko04071	Sphingolipid signaling pathway	8/99	162/7206	0.00165852051823
ko04611	Platelet activation	8/99	163/7206	0.00172465946397
ko05146	Amoebiasis	6/99	99/7206	0.00231200327925
ko04144	Endocytosis	12/99	342/7206	0.00239745810034
ko04210	Apoptosis	8/99	180/7206	0.00320519822522
ko01521	EGFR tyrosine kinase inhibitor resistance	6/99	106/7206	0.0032594337587
ko05014	Amyotrophic lateral sclerosis (ALS)	5/99	74/7206	0.00336877271777
ko04215	Apoptosis - multiple species	4/99	47/7206	0.0038030618241
ko04670	Leukocyte transendothelial migration	7/99	151/7206	0.00459741247018
ko04270	Vascular smooth muscle contraction	7/99	154/7206	0.00511772212966
ko04668	TNF signaling pathway	6/99	120/7206	0.00598661020015
ko04722	Neurotrophin signaling pathway	7/99	160/7206	0.00629020573035
ko05210	Colorectal cancer	5/99	86/7206	0.0064016522753
ko04750	Inflammatory mediator regulation of TRP channels	6/99	122/7206	0.00648137258441
ko04660	T cell receptor signaling pathway	6/99	124/7206	0.0070052928464
ko01522	Endocrine resistance	6/99	124/7206	0.0070052928464
ko04921	Oxytocin signaling pathway	8/99	209/7206	0.00782597392466
ko04068	FoxO signaling pathway	7/99	167/7206	0.00789986644303
ko05142	Chagas disease (American trypanosomiasis)	6/99	130/7206	0.0087614769349
ko04650	Natural killer cell mediated cytotoxicity	5/99	97/7206	0.0105290263939
ko04726	Serotonergic synapse	6/99	137/7206	0.0111865359128
ko04530	Tight junction	8/99	228/7206	0.0128440578997
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/99	191/7206	0.0157645383075
ko04012	ErbB signaling pathway	5/99	109/7206	0.0167911239176
ko04510	Focal adhesion	8/99	240/7206	0.0170438578136
ko04072	Phospholipase D signaling pathway	7/99	197/7206	0.01838524825
ko04623	Cytosolic DNA-sensing pathway	3/99	41/7206	0.0183864405672
ko05160	Hepatitis C	6/99	153/7206	0.0184490163825
ko05134	Legionellosis	4/99	74/7206	0.0185318590564
ko04115	p53 signaling pathway	4/99	74/7206	0.0185318590564
ko00051	Fructose and mannose metabolism	3/99	42/7206	0.0196073469567
ko01524	Platinum drug resistance	4/99	76/7206	0.02024104113
ko04730	Long-term depression	4/99	78/7206	0.022044552668
ko04130	SNARE interactions in vesicular transport	3/99	44/7206	0.0221808118444
ko05214	Glioma	4/99	79/7206	0.0229820584452
ko05200	Pathways in cancer	13/99	492/7206	0.0238502188658
ko04211	Longevity regulating pathway	5/99	123/7206	0.0267577205785
ko05164	Influenza A	6/99	167/7206	0.0270274774684
ko04910	Insulin signaling pathway	6/99	172/7206	0.0306427577465
ko04657	IL-17 signaling pathway	4/99	87/7206	0.0313563249946
ko04662	B cell receptor signaling pathway	4/99	88/7206	0.0325138514653
ko05120	Epithelial cell signaling in Helicobacter pylori infection	4/99	92/7206	0.0373930438927
ko04932	Non-alcoholic fatty liver disease (NAFLD)	6/99	182/7206	0.0387953422679
ko00261	Monobactam biosynthesis	1/99	3/7206	0.0406575682066
ko04010	MAPK signaling pathway	9/99	321/7206	0.0423944262153
ko05211	Renal cell carcinoma	4/99	96/7206	0.042672468237
ko00515	Mannose type O-glycan biosynthesis	2/99	25/7206	0.0456695330436